Patient-Defined Outcome Endpoints: A Paradigm Shift in Evaluating Atrial Fibrillation Ablation Efficacy - 29/06/21
Doi : 10.1016/j.hlc.2021.05.089
Devika Nair, MD, MSCI a, ⁎ 
, Gregory F. Michaud, MD b, Kerri L. Cavanaugh, MD, MHS a, c
, Gregory F. Michaud, MD b, Kerri L. Cavanaugh, MD, MHS a, c a Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA
b Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
c Center for Effective Health Communication, Vanderbilt University Medical Center, Nashville, TN, USA
∗Corresponding author at: Assistant Professor of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 450, Nashville, TN 37203, USAAssistant Professor of MedicineDivision of Nephrology and HypertensionVanderbilt University Medical Center2525 West End AvenueSuite 450NashvilleTN37203USA
Keywords : Patient-defined endpoints, Atrial fibrillation, Patient-reported outcomes
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2021
Pubblicato da Elsevier Masson SAS.
Vol 30 - N° 8
P. 1103-1106 - agosto 2021 Ritorno al numero
Articolo precedente
- Editorial Board
- Underusage of Oral Anticoagulation in Atrial Fibrillation: Can We Prevent More Strokes?
- Karan Rao, Ravinay Bhindi
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?